Allworth Financial’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding NVAX
SCM
S
Allworth Financial's NVAX Position: Q2 2026 in Review
Allworth Financial increased its Novavax (NVAX) stake by 293% in Q2 2026, buying an estimated $29.1K and bringing the position to 4,353 shares worth $41K. The position accounts for ﹤0.01% of the portfolio, ranked #2658.
Allworth Financial first reported a position in NVAX in Q3 2021 and has held it in 20 quarters since. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.
- Allworth Financial held 4,353 shares of Novavax worth $41K as of Q2 2026.
- Allworth Financial bought 3,244 Novavax shares in Q2 2026, an estimated $29.1K.
- Novavax made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #2658 holding.
- Allworth Financial first reported a position in Novavax in Q3 2021 and has held it in 20 quarters since.
- 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.
Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.